Choose based on preference for administration method rather than price, as the cost is equivalent at baseline doses
Efficacy and safety of modified fasting therapy for weight loss in 2054 hospitalized patients
It's an open question as to whether other GLP-1 drugs like tirzepatide the active ingredient in Mounjaro and Zepbound have similar issues, VanderBeek says
Let us know in the comments and follow for more
Mounjaro , also from Eli Lilly, is a newer GLP-1 medication that combines two hormone-like mechanisms for enhanced blood sugar control and weight management

Contact your healthcare provider within 24 hours if you experience: Persistent vomiting (more than 24 hours) preventing adequate fluid intake Severe diarrhea (more than 6 episodes daily) lasting beyond 48 hours Inability to keep down fluids despite anti-nausea measures Weight loss exceeding 23 pounds in 24 hours (likely fluid loss) Markedly reduced urine output with dark, concentrated urine New or worsening dizziness affecting daily activities or causing falls Blood glucose readings consistently above target despite usual management Seek immediate medical attention (emergency department or call 911) for: Severe, persistent abdominal pain (may indicate pancreatitis or gallbladder disease, which are labeled risks of GLP-1 medications requiring immediate evaluation and drug discontinuation) [1] Severe dizziness or fainting episodes Rapid or irregular heartbeat with chest discomfort Confusion, disorientation, or altered mental status Inability to urinate for 12+ hours Signs of acute kidney injury (decreased urine output, swelling, severe fatigue) Symptoms of hyperglycemic emergencies in diabetes patients (excessive thirst, frequent urination, fatigue, fruity breath) Patients with pre-existing kidney disease, heart failure, or those taking multiple medications affecting fluid balance should maintain closer communication with their healthcare team
